tradingkey.logo
tradingkey.logo
Search

Amylyx Pharmaceuticals Says FDA Granted Voluntary Request To Withdraw Approval Of Relyvrio

ReutersAug 28, 2025 5:42 PM
facebooktwitterlinkedin

- Amylyx Pharmaceuticals Inc AMLX.O:

  • AMYLYX PHARMACEUTICALS- SUBMITTED VOLUNTARY REQUEST TO WITHDRAW APPROVAL OF RELYVRIO FOR TREATMENT OF ALS, FDA GRANTED REQUEST

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI